Evidence map›Paper›PMID 18283287›Full record

ReviewGene therapy2008

Progress and prospects: gene therapy for performance and appearance enhancement.

M Kiuru, R G Crystal

Abstract readReview
PubMed Publisher
In one paragraph

Review in Gene therapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M KiuruDepartment of Genetic Medicine, Weill Medical College of Cornell University, New York, NY, USA.
R G Crystal

Funding

UNIDIRECTIONAL TRAFFICKING OF ADENOVIRUS VECTORSP01HL051746 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI WIVEL, NELSON A. · 1993 to 2008
$19.3M
WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPYU01HL066952 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CRYSTAL, RONALD G · 2000 to 2005
$15.9M
Gene Therapy for Batten DiseaseU01NS047458 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI CRYSTAL, RONALD G · 2005 to 2009
$7.6M
NHLBI NIH HHS P01 HL51746NHLBI NIH HHS U01 HL66952NINDS NIH HHS U01 NS047458
6 · The paper itself

Abstract

While medical therapies aim at reversing, reducing or eliminating diseases, the goal of enhancements is to improve performance or appearance beyond normal levels. Distinction between the two interventions is not always clear as they often present as a continuum. Gene therapy typically aims at treating or preventing disease, but the technology can theoretically be employed for enhancement. Some of the gene therapy enhancement strategies include improving performance by increasing muscle mass, endurance, memory, and cognition and bettering appearance by controlling weight, height and hair growth. In addition to the technical challenges of making enhancement strategies safe and effective, genetic enhancement presents significant ethical/societal questions that must be addressed.

Indexed as

Genetic EnhancementBeautyBiomedical EnhancementEthics, MedicalEugenicsGenetic TherapyHumansSafety

Identifiers

PMID18283287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.